BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 6085869)

  • 21. [Genetic observations on 44 cases of acquired heart disease].
    ALLORI L; VITAMIA P
    Acta Genet Med Gemellol (Roma); 1958 Jul; 7(3):397-410. PubMed ID: 13570900
    [No Abstract]   [Full Text] [Related]  

  • 22. Comprehensive analysis of antibody responses to streptococcal and tissue antigens in patients with acute rheumatic fever.
    Martins TB; Hoffman JL; Augustine NH; Phansalkar AR; Fischetti VA; Zabriskie JB; Cleary PP; Musser JM; Veasy LG; Hill HR
    Int Immunol; 2008 Mar; 20(3):445-52. PubMed ID: 18245783
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic variation in Bougainville and Solomon Islands populations.
    Lai LY; Bloom J
    Am J Phys Anthropol; 1982 Aug; 58(4):369-82. PubMed ID: 6812432
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Elevated hemoglobin-A2 levels in rheumatic fever and rheumatic heart disease: a new finding.
    Reddi YR; Sudhakar Rao V; Reddi GD; Niranjan Rao P; Nair R; Ahuja YR
    Indian Pediatr; 1976 Feb; 13(2):153-4. PubMed ID: 1278960
    [No Abstract]   [Full Text] [Related]  

  • 25. Lewis blood group and ABH secretor systems in some Jewish populations of Israel.
    Kobyliansky E; Micle S; Goldschmidt-Nathan M; Arensburg B; Nathan H
    Acta Anthropogenet; 1982; 6(3):133-40. PubMed ID: 7182009
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ABO blood groups and secretor character in rheumatic carditis.
    CLARKE CA; McCONNELL RB; SHEPPARD PM
    Br Med J; 1960 Jan; 1(5165):21-3. PubMed ID: 13810495
    [No Abstract]   [Full Text] [Related]  

  • 27. Functional MASP2 gene polymorphism in patients with history of rheumatic fever.
    Schafranski MD; Pereira Ferrari L; Scherner D; Torres R; de Messias-Reason IJ
    Hum Immunol; 2008 Jan; 69(1):41-4. PubMed ID: 18295674
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Serum haptoglobin levels in patients with active and inactive rheumatic fever.
    Meriç N; Ileriye D; Kaçar M; Ozkan K
    Turk J Pediatr; 1983; 25(1):41-8. PubMed ID: 6649076
    [No Abstract]   [Full Text] [Related]  

  • 29. An association between Gc (vitamin D-binding protein) alleles and susceptibility to rheumatic fever.
    Bahr GM; Eales LJ; Nye KE; Majeed HA; Yousof AM; Behbehani K; Rook GA
    Immunology; 1989 May; 67(1):126-8. PubMed ID: 2737695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. No association between secretor status of ABO blood group antigens and juvenile periodontitis.
    Frías MT; López NJ
    Acta Odontol Latinoam; 1994-1995; 8(2):9-15. PubMed ID: 11885229
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cell surface markers and cellular immune response associated with rheumatic heart disease: complex segregation analysis.
    Rich SS; Gray ED; Talbot R; Martin D; Cairns L; Zabriskie JB; Braun D; Regelmann WE
    Genet Epidemiol; 1988; 5(6):463-70. PubMed ID: 3209057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activity of lipid peroxidation processes in children with rheumatic fever].
    Shanidze ES; Zhvaniia MA
    Georgian Med News; 2005 Feb; (119):55-7. PubMed ID: 15834183
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A genetic marker for rheumatic heart disease.
    Rajapakse CN; Halim K; Al-Orainey I; Al-Nozha M; Al-Aska AK
    Br Heart J; 1987 Dec; 58(6):659-62. PubMed ID: 3501302
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A METHOD FOR DIFFERENTIATING HOMOZYGOUS FROM HETEROZYGOUS SECRETORS OF ABH BLOOD-GROUP SUBSTANCES. ITS APPLICATION TO THE STUDY OF SECRETOR STATUS IN RHEUMATIC FEVER.
    KAKLAMANIS E; HOLBOROW EJ; GLYNN LE
    Lancet; 1964 Apr; 1(7337):788-90. PubMed ID: 14108003
    [No Abstract]   [Full Text] [Related]  

  • 35. [Behavior of the antistreptolysin-O titer in rheumatic disease].
    BONAZZA R
    Minerva Med; 1958 May; 49(38):1886-9. PubMed ID: 13565584
    [No Abstract]   [Full Text] [Related]  

  • 36. Further observations and characterization of monoclonal antibodies reacting with B cell alloantigens associated with rheumatic fever and rheumatic heart disease.
    Kumar D; Kaur S; Grover A; Bali H; Khanduja KL; Kaplan EL; Gray ED; Ganguly NK
    J Lab Clin Med; 2000 Mar; 135(3):287-93. PubMed ID: 10711868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic criteria of rheumatic fever in a New Zealand community.
    Stanhope JM; Clarkson PM; Philipp R
    Aust N Z J Med; 1981 Jun; 11(3):234-42. PubMed ID: 6945833
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Study of serum mucoproteins in the evolution of infantile rheumatic heart disease].
    Hurmuzache E; Tudoranu A; Teodorescu E; Haidău L
    Pediatria (Bucur); 1968; 17(2):115-8. PubMed ID: 5669067
    [No Abstract]   [Full Text] [Related]  

  • 39. Cytotoxicity of a non-HLA serum towards lymphocytes from blood group B, Lewis negative and ABH secretor individuals.
    Mittal KK; Naik S
    Acta Anthropogenet; 1983; 7(3):249-56. PubMed ID: 6680662
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Study of C-reactive protein in children with rheumatic disease].
    FORTINA A; BULLIO D; MONGILARDI GM
    Minerva Pediatr; 1958 Jan; 10(3-4):68-71. PubMed ID: 13541140
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.